Literature DB >> 9476235

Serologic and parasitologic survey of the endangered Attwater's prairie chicken.

M J Peterson1, J R Purvis, J R Lichtenfels, T M Craig, N O Dronen, N J Silvy.   

Abstract

Because conservation biologists have postulated that infectious diseases may have potentiated the endangerment of the Attwater's prairie chicken (Tympanuchus cupido attwateri), free-living prairie chickens were surveyed from all remaining populations for helminthic endoparasites and antibody against the etiological agents of nine infectious diseases. Samples from 4 of 27 adult males were positive for anti-Pasteurella multocida antibody. All other serologic tests were negative (n = 19). We identified Dispharynx nasuta, a parasite previously associated with disease in other grouse from North America, in one of three adult Attwater's prairie chickens examined. Evidence of Trichostrongylus cramae was found for eight of nine suitable samples, which represents the first report of this parasite in prairie grouse. The mean intensity of T. cramae in Attwater's prairie chicken was 1,019.3 (Range = 3-1,906; n = 3). Further work is needed to determine whether P. multocida, T. cramae, or D. nasuta are detrimental to Attwater's prairie chicken populations. If so, conservation biologists could reduce the prevalence and incidence of these parasites and potentially gain more time to address the habitat conditions thought to be the ultimate cause of population declines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9476235     DOI: 10.7589/0090-3558-34.1.137

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  1 in total

1.  Haemosporida prevalence and diversity are similar in endangered wild whooping cranes (Grus americana) and sympatric sandhill cranes (Grus canadensis).

Authors:  Miranda R Bertram; Gabriel L Hamer; Barry K Hartup; Karen F Snowden; Matthew C Medeiros; Sarah A Hamer
Journal:  Parasitology       Date:  2016-12-12       Impact factor: 3.234

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.